Bruguiesulfurol, a new sulfur compound from Bruguiera gymnorrhiza

被引:28
作者
Homhual, S
Zhang, HJ
Bunyapraphatsara, N [1 ]
Kondratyuk, TP
Santarsiero, BD
Mesecar, AD
Herunsalee, A
Chaukul, W
Pezzuto, JM
Fong, HHS
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmacognosy, Bangkok 10400, Thailand
[2] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Program Collaborat Res Pharmaceut Sci, Chicago, IL USA
[3] Purdue Univ, Coll Pharm Nursing & Hlth Sci, W Lafayette, IN 47907 USA
[4] Univ Illinois, Coll Pharm, Ctr Pharmaceut Biotechnol, Dept Med Chem & Pharmacognosy, Chicago, IL USA
[5] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand
[6] Mahidol Univ, Fac Pharm, Dept Pharmaceut Bot, Bangkok 10700, Thailand
关键词
Bruguiera gymnorrhiza; Rhizophoraceae; ARE induction; NF-kappa B inhibition; COX-1; COX-2; dithiosulfonate; bruguiesulfurol; X-ray; NMR;
D O I
10.1055/s-2005-873171
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
A new cyclic 4-hydroxy-dithiosulfonate, bruguiesulfurol (1), as well as two known 4-hydroxydithiolane 1-oxides, brugierol (2) and isobrugierol (3) were isolated from the flowers of Bruguiera gymnorrhiza. With stably-transfected HepG2 cells, the three isolates activated antioxidant response element (ARE) luciferase activation with (EC50) values of 56.7, 3.7 and 1.8 mu M, respectively. Compounds 2 and 3 also inhibited phorbol ester-induced NF-kappa B (nuclear factor-kappa B) luciferase activity with IC50 Values of 85.0 and 14.5 mu M, respectively. In addition, compound 2 inhibited enzyme cyclooxygenase-2 (COX-2) activity with an IC50 value of 6.1 mu M, The structures of these isolates were determined by spectral data, and that of compound 1 was confirmed by X-ray crystallographic analysis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 33 条
[1]   COMPLETION AND REFINEMENT OF CRYSTAL-STRUCTURES WITH SIR92 [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, C ;
GUAGLIARDI, A .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 (pt 3) :343-350
[2]  
[Anonymous], 2005, CANC DRUG DISC DEV
[3]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[4]  
BAMRUNGRUGSA N, 1999, SONGKLANAKARIN J SCI, V3, P377
[5]  
CHEN CA, 1988, BIOTECHNIQUES, V6, P632
[6]  
Cuendet M, 2000, Drug Metabol Drug Interact, V17, P109
[7]  
EARASHI M, 1995, ONCOLOGY-BASEL, V52, P150
[9]  
Farrugia L. J., 1999, J. Appl. Crystallogr, V32, P837, DOI DOI 10.1107/S0021889899006020
[10]   ROTENOIDS MEDIATE POTENT CANCER CHEMOPREVENTIVE ACTIVITY THROUGH TRANSCRIPTIONAL REGULATION OF ORNITHINE DECARBOXYLASE [J].
GERHAUSER, C ;
MAR, W ;
LEE, SK ;
SUH, N ;
LUO, YD ;
KOSMEDER, J ;
LUYENGI, L ;
FONG, HHS ;
KINGHORN, AD ;
MORIARTY, RM ;
MEHTA, RG ;
CONSTANTINOU, A ;
MOON, RC ;
PEZZUTO, JM .
NATURE MEDICINE, 1995, 1 (03) :260-266